Cereno Scientific launches season 2 of the Insights Video Series
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced the launch of season 2 of the Insights Video Series recorded at the ESC Congress in August 2023. The video series will provide insights into the company’s drug development portfolio focused on treatments for pulmonary arterial hypertension (PAH) and thrombosis prevention, through interviews and conversations with global thought leaders.The Insights Series is conducted as a series of interviews and conversations with internationally renowned